Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Action antagonists |
Mechanism αvβ6 antagonists(Integrin alpha-V/beta-6 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | Germany | 03 May 2017 | |
Non-Small Cell Lung Cancer | Preclinical | Germany | 03 May 2017 | |
Squamous Cell Carcinoma of Head and Neck | Preclinical | Germany | 03 May 2017 | |
Squamous Cell Carcinoma of Head and Neck | Preclinical | Germany | 03 May 2017 |